Pharmacists in Kenilworth, NJ Accepting Medicare
9 Pharmacists found. Showing 1 - 9
 Laurie Wade, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 801 Boulevard, Kenilworth, NJ 07033 Phone: 908-241-5421 |
Seewan Auyeung, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2000 Galloping Hill Rd, Kenilworth, NJ 07033 Phone: 908-740-4113 |
Rashmitaben Patel Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 501 Boulevard, Kenilworth, NJ 07033 Phone: 908-276-8540 |
Alisa Lo Franco Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 21 N 20th St, Kenilworth, NJ 07033 Phone: 908-705-5911 |
 Mr. Paul Morabito, RPH REGISTERED PHARM Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 21 North 20th Street, Morabitos Pharmacy, Kenilworth, NJ 07033 Phone: 908-709-1414 Fax: 908-709-1543 |
Dana Magnusson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 801 Boulevard, Kenilworth, NJ 07033 Phone: 908-241-5421 |
Mr. Sanjay P Shah Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 501 Boulevard, Kenilworth, NJ 07033 Phone: 908-276-8540 |
Michael Abrams, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 801 Kenilworth Blvd, Kenilworth, NJ 07033 Phone: 908-259-0720 |
Dominick Morabito, RPH REGISTERED PHARM Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 21 N 20th St, Kenilworth, NJ 07033 Phone: 908-709-1414 |
News Archive
Tetraphase provides clinical update on lead antibiotic candidate and Phase 3 clinical program
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
Scientists discover how DNA mismatch repair proteins work
In eukaryotes - the group of organisms that include humans - a key to survival is the ability of certain proteins to quickly and accurately repair genetic errors that occur when DNA is replicated to make new cells.
Par Pharmaceutical reports total revenues of $1,193.2 million for 2009
Par Pharmaceutical Companies, Inc. today reported results for the fourth quarter and full year ended December 31, 2009.
Molecular ticket determines RNA's destination and speed inside egg cell
Like any law-abiding train passenger, a molecule called oskar RNA carries a stamped ticket detailing its destination and form of transport, scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany, have found.
› Verified 6 days ago
Pharmacists
Dentists
Counselors
Clinical Social Workers
Psychologists